US Pharma and Biotech Summit

The US biopharmaceutical industry faces relentless disruption. America leads the world in high-risk drug development, but how will President Trump's health policy picks stamp their authority? Advances in AI are accelerating innovation, but when will they generate returns and how will they transform workforces?   

Stay informed and connected by attending the US Pharma and Biotech Summit 2025. Organized by FT Live in collaboration with Endpoints News, the event will bring together top executives, investors and experts to share powerful insights into the future of life sciences in America and worldwide.

Gain access to in-person sessions and networking drinks. Network and connect with your peers.

Access to live talks, Q&A and video on demand. Join from the comfort of your home or office.

Artificial intelligence in life sciences 
Where is AI delivering return on investment for biopharma companies? 

Dealmaking environment
Is dealmaking activity set to surge with rate cuts? 

Clinical trial agility
How are industry-wide shifts in R&D affecting pipeline success rates? 

Learn

how America's life sciences landscape is evolving in areas such as innovation, commercialization and regulation

Engage

with C-suite executives responsible for the big decisions in areas such as funding, workforce development and strategic partnerships

Enjoy

the opportunity to network with peers and build relationships in a friendly but focused environment

Global Pharma and Biotech Summit

11-12 November 2025 | In-Person & Digital

London

Speaking Opportunities

Ciaran Larkin
ciaran.larkin@ft.com

Sponsorship

Holly Watson-Steward
holly.watson-steward@ft.com  

Delegate Services 

Hauwra Sharif
hauwra.sharif@ft.com 

© Financial Times Live

FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice